The lung cancer is the neoplastic disease more deadly in Latin America and the one that receives less attention from the health sector, revealed the study "The lung cancer in Latin America: it's time to stop looking at the other way," conducted by The Economist Intelligence Unit (EIU) ).
The study, presented at the Mexican Society of Oncology (SMEO) conference, analyzed data from 12 Latin American countries, indicating that in Mexico 99% of cases lung cancer are diagnosed in phase three or four, while in the other countries in the region the figure is 85%.
Irini One, EIU's World Editor, said that with regard to this type of cancer, there is no record
Several items in the Latin American region, so we tried to identify three priority areas in health policies for cancer control: tobacco control, access and early diagnosis.
Health experts who have collaborated with the research find that the stigma for this type of cancer is an obstacle that prevents the dedication of more specific policies and resources than other types of cancer.
"It is believed that patients who smoke took the disease," said Dr. Oscar Arrieta, head of the Lung Unit of the National Institute of Cancer Research (INCan), and pointed out that smoking is an addiction in which the Mexican state "has done enough to prevent it."
Although smoking remains the main cause of smoking
lung cancer 40% is due to unrelated causes, such as the presence of arsenic in water, air pollution and the use of firewood as a fuel in kitchens.
In Mexico, this type of cancer is not covered by the Seguro people – which covers more than 40% of the population without private insurance or social security, which contributes to the country's low level in the country. tobacco control, access and early diagnosis.
In Latin America, 60,000 people die each year from lung cancer, while in Mexico in 2010, 10,000 new cases were diagnosed and, according to Arrieta, by 2025 the number is expected to double to 20,000. that "the mortality rate will be very similar".
Ricardo Pérez Cuevas, director of research at the National Institute of Public Health, said the study reflects challenges to improve the prevention, diagnosis and treatment of lung cancer and there is no single answer to the problems associated with it in Latin America. Latina
Pérez Cuevas said that in Mexico INCan, the Mexican Health Institute and the National Institute of Public Health are working on a proposal based on the cost of
fight lung cancer and smoking, which will be presented to the Mexican authorities.
"Our hope is that lung cancer policy is stable, has the required background, and we can move on to accessing and delivering efficacy," the expert said.